State Street Corp Next Cure, Inc. Transaction History
State Street Corp
- $2.36 Trillion
- Q1 2025
A detailed history of State Street Corp transactions in Next Cure, Inc. stock. As of the latest transaction made, State Street Corp holds 65,392 shares of NXTC stock, worth $31,388. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65,392
Previous 65,392
-0.0%
Holding current value
$31,388
Previous $50,000
38.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NXTC
# of Institutions
38Shares Held
13.7MCall Options Held
1.7KPut Options Held
0-
Sofinnova Investments, Inc. Menlo Park, CA2.67MShares$1.28 Million0.09% of portfolio
-
Affinity Asset Advisors, LLC New York, NY2.3MShares$1.11 Million0.12% of portfolio
-
Citigroup Inc1.42MShares$681,2970.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA1.14MShares$547,7760.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA987KShares$473,9150.0% of portfolio
About NextCure, Inc.
- Ticker NXTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,748,800
- Market Cap $13.3M
- Description
- NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...